Skip to main content

Table 3 Two genotype frequencies of prostate cancer between Pca and control group

From: Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer

SNP

PCA(N=108)

Controll (N=242)

OR (95% CI)

n%

rs2735839

    

AA

15(13 89)

90(37.19)

1.0 (reference)

 

AG

68(62.96)

108(44.63)

3.78(2.02)-7.06

 

GG

25(23.15)

44(18.18)

3.41(1.64-7.11)

 

GG+AG

93 (86.11)

152(62.81)

3.679(2.01-6.72)

 

rs731236

    

TT

96(88.89)

219(90.50)

1.0(reference)

 

TC

10(9.26)

22(9.10)

1.04(0.47-2.27)

 

CC

2(1.85)

1(0.40)

456(0.41-50.92)

 

CC+CT

12(11.11)

23(9.51)

1.19(0.57-2.49)

 
  1. PCa: Prostate cancer; SNP: single nucleotide polymorphism; a 95% Coincidence interval.